Prof. Dr. Ing. Yuanhui Ji
. References [1] M. Kennedy, J. Hu, P. Gao, L. Li, A. Ali-Reynolds, B. Chal, V. Gupta, C. Ma, N. Mahajan, A. Akrami, and S. Surapaneni: "Enhanced Bioavaolability of a Poorly Soluble VR1 Antagonist Using [...] pharmaceuticals is hindered by their poor aqueous solubilities which result in a poor bioavailability [1]. Amorphous pharmaceuticals hold potential to enhance the dissolution rate for poorly water-soluble …